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Abstract: 
Working capital policy can be best described as a strategy, which provides the guideline to manage the 
current assets and the current liabilities in a way that it reduces the risk of default (Brian, 2009). Working capital 
policy mainly focuses on the liquidity of current assets to meet the current liabilities. A company can adopt any 
of the three approaches to working capital, namely: matching approach, conservative approach and aggressive 
approach (Omolumo 1997).In this article, an evaluation of working capital policies of the select pharmaceutical 
companies are carried out for ten year period from 2006 to 2015. The types of current assets investment and 
financing policies adopted by the sample pharma companies are analyzed first, differences in policies are 
presented next which is followed by the analysis of stability in policies over the period of study.  Also the 
relationship between current assets investment and financing policies is examined and finally changes in 
policies are studied. 
1. Introduction: 
Working capital policy refers to the policy adopted in the management of short term assets and 
liabilities. Working capital management is really vital for the short term financial health of a business no matter 
what is its size. For the growth and survival of firms efficient working capital management is indeed a 
requirement. Financial distress leading to bankruptcy is believed to be a result of poor short term asset and 
liability management. Exercising of proper working capital policy and maintenance of proper finance are very 
important for every organization and they have a significant impact on a company’s performance and growth.  
Mismanagement and starvation of working capital is regarded as the important cause, if not major, for the 
failure of business in many countries, developed and underdeveloped. Management of short term assets and 
liabilities warrants a careful investigation since the working capital management plays an important role for the 
firm’s profitability and risk as well as its value (Smith, 1980). Firms try to keep an optimal level of working 
capital that maximizes their value (Howorth and Westhead 2003, Deloof 2003). A firm may adopt an aggressive 
working capital management policy with a low level of current assets as percentage of total assets. Moreover an 
aggressive working capital management policy may be used for the financing decisions of the firm with high 
level of current liabilities as percentage of total liabilities. Excessive level of current assets may have a negative 
effect on the firm’s profitability whereas a low level of current assets may lead to lower level of liquidity and 
stock outs resulting in difficulties in maintaining smooth operations (Van Horne and Wachowicz 2004). In this 
article, an evaluation of working capital policies of the select pharmaceutical companies are carried out. The 
types of current assets investment and financing policies adopted by the sample pharma companies are analyzed 
first; differences in policies are presented next which is followed by the analysis of stability in policies over the 
period of study.  Also the relationship between current assets investment and financing policies is examined.  
And finally changes in policies are studied.  
The Objectives of the Study are as Follows: 
 To investigate whether there is a significant difference among the working capital practices of the firms 
across different firms  
 To analyze whether these aggressive or conservative working capital policies relatively stable over the 
period of time.  
 To validate the relationship of aggressive and conservative working capital policies among firms and 
see whether an aggressive policy accompanied by aggressive financing policy.  
 To examine the relationship in the changes among the study between aggressive and conservative 
working capital policies. 
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2. Literature Review:  
Weinraub and Visscher (1998) have discussed the issue of aggressive and conservative working capital 
management policies for a period of 10 years from 1984 to 1993 of US firms. This study looked at ten diverse 
industry groups to examine the relative relationship between their aggressive/conservative working capital 
policies .Their study also revealed that the relative nature of the working capital management policies exhibited 
remarkable stability over the 10-year study period and a high and significant negative correlation between 
industry asset and liability policies. They also found that when relatively aggressive working capital investment 
policies are followed, they are balanced by relatively conservative working capital financing policies. 
Rahaman and Florin (2007) investigated the relative relationship between aggressive and conservative 
working capital practices of six major manufacturing industries over a period of five years in Bangladesh. 
Analysis revealed that working capital investment policies of Pharmaceutical, Textile, and Food, Engineering, 
Cement and miscellaneous industries are not significantly different but their working capital financing policies 
are different. They also measured the degree of relationship about how aggressive asset management 
corresponds to aggressive financial management. It is evident that relative aggressive working capital 
management is balanced by relatively conservative working capital financial management. 
Nazir and Afza (2009) investigate the relationship between the policies that firms adopt to deal with the 
working capital and firms profitability by using data on 204 non- financial firms listed in Karachi Stock 
Exchange (KSE). The results indicate a negative relationship between firms’ profitability and its financing 
policies, the firm that adopt an aggressive working capital policy generate a lower rate of return than that of 
those adopting a conservative working capital policy. 
Mona Al-Mwalla (2012) investigate the impact of working capital management policies (aggressive 
and conservative policies) on the firms’ profitability and value by using data of 57 industrial firms listed in 
Amman Stocks Market for the period of 2001 to 2009, the results show that following a conservative investment 
policy has a positive impact on a firm’s profitability and value and following the aggressive financing policy has 
a negative impact on the firm’s profitability and value. Finally, this study finds that firm Size, firm Growth and 
GDP Growth has a positive impact on the firm’s profitability and value with no effect of financial leverage. 
Taghizadeh Khanqah Vahid, Akbari Khosroshahi Mohsen and Ebrati Mohammadreza (2012) 
investigate the impact of working capital management policies (aggressive and conservative policies) on the 
firms’ profitability and value. A sample of 28 Iranian Companies listed on Tehran Stock Exchange for a period 
of 5 years from 2005 to 2009 was selected. The results show that following a conservative investment policy 
and aggressive financing policy has a negative impact on a firm’s profitability and value. The study also  finds 
that firm Size and firm Growth has a positive impact on the firm’s profitability and value, while firm leverage 
show negative impact. 
Dr. Faris Nasif (2011) investigates the relationship between the aggressive/conservative working 
capital policies for 59 industrial companies listed at the Amman Stock Exchange for a period of 2004-2007. The 
impact of aggressive/conservative working capital investment and financing policies has been examined through 
cross-sectional regression models between working capital policies and profitability as well as the risk of the 
firms. The result indicates a negative relationship between the profitability measures of firms and degree of 
aggressiveness of working capital investment and financing policy.  
Atif Hussain, Syed Umar Farooq and Kaleem Ullah Khan (2012) empirically investigate the 
relationship between working capital management and profitability. Date set consists of companies listed in 
Karachi Stock Exchange for the period of 2006-2010. Correlation and panel data regression using fixed effect 
are used for testing hypotheses to determine the association between the independent variables (Returnon 
Investment and Return on Equity) and independent variables (Aggressive Investment Policy and Aggressive 
Financing Policy) along with control variables (Company Size, Sale Growth, Leverage Ratio and GDP growth). 
The result revealed that low investment in current assets and low current liability financing increases the 
profitability of firms. The study also suggested that company size, sale growth and leverage ratio significantly 
affect the profitability of the firm. This reveals that profitability of the firm is significantly affected by the 
working capital management and working management policies. 
Md. Nazrul Islam &  Shamem Ara Mili ( 2012) examine the relative relationship between the working 
capital investment and financing practices of the five selected listed pharmaceutical companies in Bangladesh 
over a period of five years. The study found that there is a significant difference in the working capital 
investment and financing policies among the pharmaceuticals but there is an interrelation between the 
aggressive working capital investment policy corresponding to conservative working capital financing policy of 
the pharmaceuticals over the study period and vice-versa.  
 Babatunde R. Yusuf and Khadijah A. Idowu (2012) examined the relationship between working 
capital aggressiveness and financial performance of manufacturing firms in Nigeria for the period 2006 to 2010. 
The findings show that there is ‘higher’ return on assets but ‘lower’ risk involved when total assets are financed 
by aggressive current assets but higher risks with lower return when financed by aggressive current liabilities 
hence, inversely correlated. The results also depict that both aggressive current assets and liabilities will bring 
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lower returns on equity hence negatively correlated whereby higher risks involved for aggressive current assets 
and a lower risks involved for aggressive current liabilities respectively. 
3. Variables and Methodology:  
The data set includes current assets, current liabilities and total assets from a random sample of top ten 
pharmaceutical companies on the basis of market capitalization more than twenty cores and which are enlisted 
in Bombay Stock Exchange Ltd, for the period from 2006 to 2015. We have used yearly CA/TA and CL/TA 
ratios of the selected pharmaceuticals as the raw data for the study. Both primary as well as secondary sources 
of information have been considered as a data collection process. The basic source of the study’s collected data 
was “capital line data base”. The statistical tools like mean, standard deviation, tukey’s HSD and F-test (One-
way ANOVA) are adopted to reach the final conclusion of the study. For the further refinement of the findings 
Pearson rank correlation coefficient and Regression between the aggressive/conservative working capital 
investment and financing policies are also computed. The hypotheses are tested through statistical measurement 
to arrive at systematic conclusion and contribute to the further research work regarding same perspective. 
4. Aggressiveness of Current Assets Investment and Financing Policies: 
To measure the degree of aggressiveness of investment in current assets, the current assets to total 
assets ratio is used. 
AIP = 
TCA 
TA 
AIP = Aggressive Investment Policy 
TCA = Total Current Assets 
TA = Total Assets 
A lower ratio indicates a relatively more aggressive current assets investment policy. 
The total current liability to total assets ratio is used to measure the degree of aggressive financing policy. 
AFP = 
TCL 
TA 
Where  AFP = Aggressive Financing Policy 
TCL = Total Current Liabilities 
TA = Total Assets 
A high ratio indicates relative aggressiveness. 
5. Analysis and Interpretation: 
Working Capital Policies: 
Table 1: Ten Years Firms Means and Standard Deviation for Current Assets/ Total Assets and Total Current 
Liabilities/Total Assets 
Companies 
TCA/TA 
 
TCL/TA 
 
MEAN SD MEAN SD 
CIPLA 0.53 0.12 0.19 0.05 
DR.REDDY 0.42 0.11 0.19 0.03 
LUPIN 0.54 0.06 0.25 0.06 
AUROBINDO 0.57 0.10 0.21 0.06 
SUN PHARMA 0.24 0.08 0.11 0.05 
CADILA 0.35 0.04 0.24 0.06 
GLENMARK 0.36 0.17 0.21 0.11 
TORRENT 0.53 0.16 0.31 0.06 
GLAXOSMITH 0.64 0.52 0.20 0.04 
IPCA LABS 0.56 0.04 0.25 0.03 
SD: Standard Deviation 
Table 1 presents the descriptive analysis of ten pharmaceutical firms from 2006 to 2015. The TCA/TA 
ratio and TCL/TA ratios are averaged for each firm for all ten years and standard deviation has been calculated. 
It is observed from the table that the mean values of TCA/TA ratios ranges from 0.24 to 0.64.Among ten 
companies mean values of TCA/TA ratios of four companies namely Dr. Reddy, Sun pharma, Cadila and 
Glemark do not exceed 0.50 indicating that they were aggressive investment policy. A look at the financing 
policies the average TCL/TA varies from 0.11 times in Sun Pharma to 0.31 times in Torrent. It is depicted from 
the above table that all firms are following conservative financing policy which implies more usage of higher 
cost of capital namely long term debt and equity in financing their working capital. 
Differences in Policies: 
To determine if significant differences exist among the working capital investment policies of the 
select companies, one-way ANOVA test is applied to the ten-year mean values of TCA/TA ratios of the ten 
companies. The null hypothesis framed for the test is – There is no difference in the investment policy across the 
pharmaceutical companies. The mean values were also subjected to the Tukey’s Honestly Significant Difference 
(HSD) test and the results are given in Table (2) 
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Table 2: Significance Levels for Company Mean Differences of the Current Asset / Total Asset Ratio (F Test 
and Tukey’s HSD) 
* Significant at 5% level. 
The resulting value of F-Test is 1.02 which is not significant at 5%, 1% and 10%l evel indicating that 
there is no significant difference exists between the firm’s practices relating to aggressive / conservative 
investment policies. To further examine the strength of results of ANOVA, a TUKEY’S HSD test has also been 
applied to compare the firms mean value of TCA/TA on a paired sample basis. Among 45 pairs, only 4 pairs are 
statistically significant at 5% level. It is apparent from both ANOVA and TUKEY’S HSD test that significant 
difference does not exists among various firms’ investment working capital management policies. 
Table 3: Significance Levels for Company Mean Differences of the Total Current Liability / Total Asset Ratio 
(F Test and Tukey’s HSD) 
F statistic =0.198 
        
 
CIPLA DR.REDDY LUPIN 
AURO 
BINDO 
SUN 
PHARMA 
CADILA 
GLEN 
MARK 
TORRENT 
GLAXO 
SMITH 
DR.REDDY 0.05 
        
LUPIN -0.75 -5.02* 
       
AUROBINDO -0.18 -5.44* -4.64* 
      
SUN PHARMA 1.27 -0.72 0.08 -0.50 
     
CADILA -0.67 -2.29 -1.49 -2.07 -3.51 
    
GLENMARK -0.23 -2.43 -1.63 -2.21 -3.65 -1.71 
   
TORRENT -1.76 -4.90* -4.10 -4.68* -6.12* -4.18 -4.62* 
  
GLAXOSMITH -0.04 -6.56* -5.76* -6.33* -7.78* -5.84* -6.28* -4.75* 
 
IPCA LABS -0.80 -5.36* -4.56* -5.13* -6.58* -4.64* -5.08* -3.55 -5.27* 
* Significant at 5% level. 
ANOVA and HSD have also been applied to TCL/TA ratio to examine the differences in financing 
policies among firms over the study period. The results are presented in the table 3.the F-statistics is 0.198 is not 
significant at any level, which is clearly indicates that there is no significant difference among firms regarding 
working capital financing policies. Table 3 also shows 21 pairs of firms that are negatively significant at 5% 
level. It is also clear now that significant firm’s differences do not exist in the relative degree of the both 
aggressive/conservative working capital investment and financing policies. 
Stability Between Policies: 
Once the significant difference for working capital investment and financing policies are explored 
across firms, next to examine relative stability of these differences over the study period. For this purpose, a 
mean value for TA/TA has been calculated for each firm for each year and ranked from the highest to lowest 
ratio. Then the base year (2006) rankings were sequentially compared to the TCA/TA ranking of each 
succeeding year. The firms were also ranked from the lowest to highest for each year on the basis TCL/TA and 
their ranking were also compared with the base year of 2006.The rank order correlation coefficient is presented 
in the table 4. 
Table 4: Rank order correlation between base year and each succeeding year for TCA/TA and TCL/TA 
Year 
CA/TA TCL/TA 
Correlation Correlation 
2007 0.37 0.65* 
2008 0.21 0.45 
2009 0.10 0.08 
2010 -0.14 0.16 
2011 0.04 -0.14 
2012 0.16 -0.26 
2013 0.16 0.25 
2014 0.07 0.25 
2015 0.37 0.16 
*Significant at five percent level 
F Statistics = 1.02 
         
 
CIPLA DR.REDDY LUPIN 
AURO 
BINDO 
SUN 
PHARMA 
CADILA 
GLEN 
MARK 
TORRENT 
GLAXOS 
MITH 
DR.REDDY 1.55 
        
LUPIN -0.06 -1.61 
       
AUROBINDO -0.48 -2.03 -0.42 
      
SUN PHARMA 4.24 2.69 4.50* 4.72* 
     
CADILA 2.67 1.12 2.73 3.15 -1.57 
    
GLENMARK 2.53 0.98 2.59 3.01 -1.71 -0.14 
   
TORRENT 0.06 -1.49 0.12 0.54 -4.18 -2.61 -2.47 
  
GLAXOSMITH -1.59 -3.15 -1.54 -1.11 -5.84* -4.27 -4.13 -1.66 
 
IPCA LABS -0.40 -1.95 -0.34 0.09 -4.64* -3.07 -2.93 -0.46 1.20 
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The results are presented in the table 4 indicates that there is an evidence of strong instability in their 
relative conservative working capital investment policy. So the firm follows conservative working capital 
policies with changes in the components of working capital due to manufacturing of more new products. After 
examine the stability of financing policy, it is found to be not significant in all the years expect 2007 ,the 
positive correlation between financing policies indicates that firms follows aggressive investment working 
capital policy, simultaneously follow  aggressive working capital financing policy too.  
Relationship between Investment and Financing Policies:  
Table 5: Rank Correlation, Per Year, of Aggressive Asset Policies and Aggressive Financing Policies 
 
 
 
  
 
 
 
 
 
 
 
 
 
Moreover, the relationship between the working capital investment and financing policies is also 
examined in this study. The objective is to determine how an aggressive investment policy corresponds to 
aggressive financing policy. To validate this relationship, a year by year analysis has been conducted. The firms 
were ranked from low TCA/TA ratios to high, corresponding to ascending order of relatively aggressive 
policies. Ranking were also orderd,for the first year from high to low TCL/TA ratios, again corresponding to an 
ascending order of aggressiveness of working capital financing policy. Rank order correlation has performed on 
these policies for first year and all succeeding years subsequently. The results are presented in the table 5. It is 
evident from that expect all they correlation between two policies. During the ears are showing negative 
correlation and in the year 2010 it is negatively significant. From this it is clear that the firms adopted 
conservative investment policy corresponds with conservative financing policy during the study period. 
Changes in Policies: 
As it is ascertained that the policies of the companies change through the study period, the question 
arises whether the policies of all the companies change in the same direction and about the same time, indicating 
possible influence by some common macro economic factors.  Regression analysis is used to examine the 
relationship in the changes among the firms. 
Table 6: Regression between firms Current Asset / Total Asset Ratios for ten year period (R Squared and t 
values 
* Significant at 5% level ** Significant at 1% level 
The ten year current assets to total assets ratio for each firms are regressed against the ratios for each 
other firms. The results of regression of the 45 pairs of firms are presented in Table 6. It could be inferred the 
result exhibits both positive and negative relationship. The relationship is significant only in 22 pairs at five per 
Year Correlation 
2006 -0.27 
2007 -0.50 
2008 -0.33 
2009 -0.35 
2010 -0.77* 
2011 -0.38 
2012 -0.64 
2013 -0.48 
2014 -0.45 
2015 -0.49 
FIRMS CIPLA DR.REDDY LUPIN 
AURO 
BINDO 
SUN 
PHARMA 
CADILA 
GLEN 
MARK 
TORRENT 
GLAXO 
SMITH 
DR.REDDY 6.23** 
        
 
(0.83) 
        
LUPIN 3.67** 9.43** 
       
 
(0.63) (0.92) 
       
AUROBINDO 3.81** 6.64** 11.50** 
      
 
(0.60) (0.85) (0.94) 
      
SUN PHARMA -1.01 -0.14 0.10 -0.08 
     
 
(0.11) (0.00) (0.00) (0.00) 
     
CADILA -0.49 -0.07 3.71** -0.15 3.71** 
    
 
(0.03) (0.00) (0.63) (0.00) (0.63) 
    
GLENMARK -0.63 -0.23 10.62** -0.35 3.02** 10.62** 
   
 
(0.05) (0.01) (0.93) (0.02) (0.53) (0.93) 
   
TORRENT -1.04 -1.03 2.25* -1.63 1.00 2.25* 2.73* 
  
 
(0.12) (0.12) (0.39) (0.25) (0.11) (0.39) (0.48) 
  
GLAXOSMITH -0.56 -0.29 2.86* -0.69 1.25 2.86* 3.12** 3.94** 
 
 
(0.04) (0.01) (0.51) (0.06) (0.16) (0.51) (0.55) (0.66) 
 
IPCA LABS 0.10 0.21 0.10 0.02 1.30 3.06** 3.10** 2.78* 5.08** 
 
(0.00) (0.01) (0.00) (0.00) (0.17) (0.54) (0.55) (0.49) (0.76) 
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cent level and one percent level of significance. Aurobinda and Sun pharma are the only two firms which do not 
tend to change their working capital investment policies with other firms. 
Table 7: Regression between firm’s total current liabilities / total asset ratios for ten year period (R Squared and 
t values) 
* Significant at 5% level ** Significant at 1% level 
                          Regarding the changes in working capital financing policies only 17 regressions were 
significant at five percent and one per cent level of significance. The results are presented in the Table 7. 
Working capital financing policies of only Torrent is not correlated with that of any other firms. The lack of 
correlation between working capital financing policies of these companies appear to suggest that these are 
independent of any external factors. Changes in financing policies over time may depend more on industry 
factors than investment policy changes. 
6. Conclusion: 
This study looked at ten pharmaceutical companies to examine the relative relationship between their 
aggressive/conservative working capital policies. The result of the evaluation of working capital policies of the 
select companies show that majority of pharmaceutical companies are using conservative working capital 
investment policy. Similarly conservative financing policy is adopted in almost all companies.   One-way 
ANOVA and Turkey’s HSD test reveal that there is no significant difference exists in the adoption of both 
working capital investment policy and working capital financing policy across the selected companies. The 
examination of stability of the policies shows that working capital financing policies are more not stable over 
the period of study than working capital investment policy. Further, the assessment of how aggressive 
investment policy corresponds to aggressive financing policy shows that companies which pursue relatively 
aggressive or conservative working capital investment policy simultaneously follows relative aggressive or 
conservative working capital financing policy. The examination of relationship of changes in investment 
policies among the firms reveals that there is a relationship in the changes due to common economic factor. On 
the other hand changes in working capital financing policies are not due to common economic factor but due to 
company specific factors. 
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Companies CIPLA 
DR. 
REDDY 
LUPIN 
AURO 
BINDO 
SUN 
PHARMA 
CADI
LA 
GLEN 
MARK 
TORRENT 
GLAXO 
SMITH 
DR.REDDY 
2.15* 
        
(0.37) 
        
LUPIN 
2.06* 3.81** 
       
(0.35) (0.64) 
       
AUROBINDO 
0.09 2.58* 3.11** 
      
(0.00) (0.45) (0.55) 
      
SUN 
PHARMA 
-0.21 1.78 1.32 4.04** 
     
(0.01) (0.28) (0.18) (0.67) 
     
CADILA 
-1.25 0.82 0.86 3.36** 3.17** 
    
(0.16) (0.08) (0.08) (0.58) (0.56) 
    
GLENMARK 
-1.43 0.49 0.84 2.40* 1.37 2.72* 
   
(0.20) (0.03) (0.08) (0.42) (0.19) (0.48) 
   
TORRENT 
0.91 0.93 1.85 1.79 0.73 0.55 1.54 
  
(0.09) (0.10) (0.30) (0.29) (0.06) (0.04) (0.23) 
  
GLAXOSMIT
H 
0.11 1.02 1.01 2.11* 1.26 2.22* 1.73 2.16* 
 
(0.00) (0.11) (0.11) (0.36) (0.17) (0.38) (0.27) (0.37) 
 
IPCA LABS 
-0.45 0.95 0.65 2.04* 1.68 
3.69*
* 
2.16* 1.25 2.90* 
(0.02) (0.10) (0.05) (0.34) (0.26) (0.63) (0.37) (0.16) (0.51) 
